Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02215603
Other study ID # ProlongedSitting
Secondary ID
Status Recruiting
Phase N/A
First received August 7, 2014
Last updated January 12, 2016
Start date August 2014
Est. completion date December 2016

Study information

Verified date January 2016
Source Rigshospitalet, Denmark
Contact Fabiana Benatti
Phone +45 35450898
Email fabiana.braga.benatti@regionh.dk
Is FDA regulated No
Health authority Denmark: Danish Dataprotection Agency
Study type Interventional

Clinical Trial Summary

Great controversy exists with respect to the optimal or the minimum volume, intensity, and frequency of physical activity capable of attenuating the hazards of prolonged sitting on the metabolic profile. Thus, our study aims to comprehensively investigate the effects of disrupting prolonged sitting with different physical activity protocols on metabolic risk factors in sedentary males.

Ten sedentary males will take part in this randomized cross-over trial consisting of four 27-h conditions. All conditions will be identical except for the physical activity: prolonged sitting intervention (SIT) participants will sit continuously for 9 hours; prolonged sitting+interval standing intervention (STAND), participants will stand for 15 min every 30 minutes (total 270 min) during the 9 hours of sitting; prolonged sitting+moderate-intensity exercise bout (MVPA) participants will perform a 30-min moderate-intensity exercise bout on a treadmill (energy-matched to STAND), after which they will sit for the remaining time; and prolonged sitting+moderate-intensity exercise bout +interval standing intervention (MVPA-STAND), participants will perform a 30-min moderate-intensity exercise bout on a treadmill (energy-matched to STAND), after which they will stand for 15 min every 30 minutes (total 240 min) during the remaining 8 hours of sitting. Blood glucose, insulin, lipids and cytokines will be determined.

The investigators expect that disrupting prolonged sitting with intermittent standing and a moderate-exercise bout will positively affect the metabolic profile of the participants. Furthermore, we will investigate if combined, these strategies will have an additive effect.


Recruitment information / eligibility

Status Recruiting
Enrollment 10
Est. completion date December 2016
Est. primary completion date June 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 25 Years to 55 Years
Eligibility Inclusion Criteria:

- Males,

- age 25-55 y,

- BMI >18 and <35 kg/m2

Exclusion Criteria:

- Clinically diagnosed diabetes,

- dyslipidaemia,

- hypertension,

- use of glucose- and/or lipid-lowering medication,

- smoking,

- evidence of thyroid, liver, lung, heart or kidney disease,

- non-sedentary occupation and primary means of commuting to work (i.e., cycling) in the last 4 months,

- VO2max levels above the considered average fitness according to age,

- contraindication to increased levels of physical activity.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Breaking prolonged sitting with physical activity


Locations

Country Name City State
Denmark Centre of Inflammation and Metabolism Copenhagen

Sponsors (2)

Lead Sponsor Collaborator
Rigshospitalet, Denmark Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Area under the curve of cytokine postprandial responses Cytokine levels (TNF-alpha, IL-6, IL-10, and IL1-ra) will be assessed 10 min before, and 30, 60, 120 and 180 min after each main meal. These postprandial responses will be defined as the area under the curve (AUC) assessed over the 3-h period after each main meal (3-h AUC) and the cumulative AUC after all main meals (12-h AUC). 27 h No
Primary Area under the curve of glucose and insulin postprandial responses Glucose and insulin levels will be assessed 10 min before, and 30, 60, 120 and 180 min after each main meal. These postprandial responses will be defined as the area under the curve (AUC) assessed over the 3-h period after each main meal (3-h AUC) and the cumulative AUC after all main meals (12-h AUC). 27 h No
Secondary Glucose levels Glucose incursions will measured using the glucose monitoring (CGM) system throughout the 27 hours. Mean, maximum and minimum glucose values during the 27h will be the outcome measures (mmol/l). 27 hours No
Secondary Area under the curve of lipid postprandial responses Lipid levels will be assessed 10 min before, and 30, 60, 120 and 180 min after each main meal. These postprandial responses will be defined as the area under the curve (AUC) assessed over the 3-h period after each main meal (3-h AUC) and the cumulative AUC after all main meals (12-h AUC). 27 h No